Ahencio, Belen A.

HRN: 26-18-84  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/09/2024
11/16/2024
IV
4.5g
Q8h
Infected Wound
Waiting Final Action 
11/10/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/10/2024
11/16/2024
IV
600mg
Q8
DM Foot, Left
Waiting Final Action 
11/17/2024
CLINDAMYCIN 300MG (CAP)
11/17/2024
11/23/2024
PO
300
TID
S/P Wound Debridement, Cellulitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: